Success Story: NIW Approved Without RFE! We Helped An Organic Chemistry Researcher Achieve Success
Client’s Testimonial:
"Thank you so much for everything you've done. It has been a pleasure working with you, and I truly appreciate all of your hard work and support.”
On June 20th, 2026, we received another EB-2 NIW (National Interest Waiver) approval for a Research Scientist in the Field of Organic Chemistry (Approval Notice).
General Field: Organic Chemistry
Position at the Time of Case Filing: Research Scientist
Country of Origin: China
State of Residence at the Time of Filing: Massachusetts
Approval Notice Date: June 20th, 2026
Processing Time: 5 months, 29 days (Premium Processing Upgrade Requested)
Case Summary:
The client is a researcher trained at the doctoral level in chemistry, holding a Ph.D. in chemistry and specializing in organic chemistry and synthetic methodology development. At the time of filing, the client was engaged in research in a highly advanced industry setting, where the focus of work involves applying synthetic chemistry tools to solve complex challenges in drug development and molecular engineering.
The approved I-140 National Interest Waiver (NIW) petition recognizes the client’s contributions in advancing new chemical strategies that support next-generation therapeutic development, particularly in the area of oligonucleotide chemistry and bioconjugation systems.
Overview of the Proposed Endeavor
The client’s proposed endeavor focuses on creating innovative organic chemistry tools and synthetic molecules designed to enable the discovery and optimization of new oligonucleotide and conjugation chemistries. This research aims to support more efficient drug discovery processes, advance genetic medicine, and ultimately improve human health outcomes.
We demonstrated that this work carries substantial merit and national importance because it directly addresses long-standing challenges in therapeutic delivery and molecular precision. Oligonucleotide-based therapies represent an emerging class of treatments, but their effectiveness depends heavily on overcoming barriers related to stability, specificity, and intracellular delivery. The client’s research targets these challenges through chemical innovation that enhances pharmacological performance and therapeutic reliability.
Evidence of Research Productivity and Scholarly Impact
The client’s professional record demonstrates consistent research output and growing influence within the field of organic chemistry and chemical biology. The petition highlighted:
- 4 peer-reviewed journal articles (including 2 co-first-authored papers)
- 1 first-authored conference abstract
- 259 citations to published work
Rather than treating these metrics as standalone achievements, we demonstrated how they reflect meaningful scientific impact. The citation record indicates that the client’s methodologies in organic synthesis and conjugation chemistry are being actively referenced by other researchers working on molecular modification, drug delivery systems, and synthetic methodology development.
Conclusion and NIW Outcome
Taken together, the evidence showed that the client possesses a strong combination of advanced training, original research contributions, peer-recognized publications, and independent validation through citations. We demonstrated that the client is well positioned to continue advancing impactful research in organic chemistry with direct applications in drug discovery and genetic medicine.
Accordingly, the National Interest Waiver petition was approved, recognizing the national importance of the client’s work in developing next-generation chemical tools for biomedical innovation in the United States.